Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B

Nasvac (HeberNasvac(®)) is a novel therapeutic vaccine for chronic hepatitis B (CHB). This product is a formulation of the core (HBcAg) and surface (HBsAg) antigens of the hepatitis B virus (HBV), administered by nasal and subcutaneous routes, in a distinctive schedule of immunizations. In the prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar, Julio Cesar, Aguiar, Jorge Agustin, Akbar, Sheikh Mohammad Fazle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787858/
https://www.ncbi.nlm.nih.gov/pubmed/36560498
http://dx.doi.org/10.3390/vaccines10122087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787858/
https://www.ncbi.nlm.nih.gov/pubmed/36560498
http://dx.doi.org/10.3390/vaccines10122087

Ejemplares similares